DOI: 10.1055/s-00023610

Drug Research

References

Barnett AH, Mithal A, Manassie J. et al.
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial.

Lancet Diabetes Endocrinol 2014;
2: 369-384

Download Bibliographical Data

Access:
Access:
Access: